Announcement on Using Common Reserve to Offset Losses and Notifying Creditors

Harbin Honor Pharmaceutical Co., Ltd. Stock Code: 002437 Stock Abbreviation: Honor Pharmaceutical Announcement No.: 2026-040

Announcement on Using Common Reserve to Offset Losses and Notifying Creditors

The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.

I. Reason for Notifying Creditors

Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") passed the "Proposal on Using Common Reserve to Offset Losses" at the ninth meeting of the seventh Board of Directors held on April 24, 2026, and the 2025 Annual Shareholders' Meeting held on May 18, 2026.

According to the "Audit Report" issued by Shangshih Certified Public Accountants (Special General Partnership), as of December 31, 2025, the Company's parent company's statement showed undistributed profits of -254,980,100.25 yuan, common reserve of 0 yuan, and capital reserve of 755,423,598.76 yuan; the consolidated statement showed undistributed profits of -304,535,582.82 yuan, common reserve of 0 yuan, and capital reserve of 413,293,060.26 yuan.